Brian P. Tullius

Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies

Md Faqrul Hasan, Amanda R. Campbell, Tayler J. Croom-Perez et al. · Journal for ImmunoTherapy of Cancer · 2023 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17

The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH

Brian P. Tullius, Uma H. Athale, C. Heleen van Ommen et al. · Journal of Thrombosis and Haemostasis · 2017 · 21 citations · Full text

Medicine, Oncology, Pediatrics +16

Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity

Meisam Naeimi Kararoudi, Brian P. Tullius, Nitin Chakravarti et al. · Seminars in Hematology · 2020 · 21 citations · Full text

Life Sciences, Immunology, Oncology +16